Top compounds associated with response to LGALS9C

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	parbendazole	CTRPv2	pan-cancer	AAC	0.0027	0.9
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.003	0.9
mRNA	Topotecan	CTRPv2	pan-cancer	AAC	0.0027	0.9
mRNA	Cytarabine	CTRPv2	pan-cancer	AAC	-0.0023	0.9
mRNA	BRD-K34222889	CTRPv2	pan-cancer	AAC	0.0026	0.9
mRNA	navitoclax:pluripotin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.0029	0.9
mRNA	CHIR-99021	CTRPv2	pan-cancer	AAC	-0.0027	0.9
mRNA	cabozantinib	CTRPv2	pan-cancer	AAC	-0.0029	0.9
mRNA	BYL-719	CTRPv2	pan-cancer	AAC	-0.0032	0.9
mRNA	CAL-101	CTRPv2	pan-cancer	AAC	0.0027	0.9

Download CSV